Hampton, New Jersey
United States
41
2026-02-26
26
2024-05-21
These are the the leading inventors for applications assigned to CELLDEX THERAPEUTICS, INC.:
CELLDEX THERAPEUTICS, INC. based in Hampton, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ANTI-KIT ANTIBODY FORMULATIONS AND METHODS
#2 | 2025-05-15USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT
#3 | 2024-10-31USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT
#4 | 2024-08-29TREATMENT OF EOSINOPHIL OR MAST CELL RELATED DISORDERS
#5 | 2024-05-09ANTI-KIT ANTIBODIES AND USES THEREOF
#6 | 2024-04-11ANTI-KIT ANTIBODIES AND USES THEREOF
#7 | 2024-04-04TREATMENT OF CHRONIC PRURIGO
#8 | 2022-06-09ANTI-AXL ANTIBODIES AND METHODS OF USE THEREOF
#9 | 2022-02-24 ✅ Patent 11,987,626 granted on 2024-05-21Treatment of eosinophil or mast cell related disorders
#10 | 2022-01-27 ✅ Patent 11,332,537 granted on 2022-05-17Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs
#11 | 2022-01-13 ✅ Patent 11,891,452 granted on 2024-02-06Anti-kit antibodies and uses thereof
#12 | 2021-07-01ANTI-CD27 AND ANTI-PD-L1 ANTIBODIES AND BISPECIFIC CONSTRUCTS
#13 | 2021-05-20AGONISTIC ANTIBODIES THAT BIND CD40
#14 | 2021-05-13 ✅ Patent 11,965,031 granted on 2024-04-23Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
#15 | 2021-05-06 ✅ Patent 11,884,734 granted on 2024-01-30Anti-MET antibodies and methods of use thereof
#16 | 2020-12-10 ✅ Patent 11,884,699 granted on 2024-01-30Anti-KIT antibodies and uses thereof
#17 | 2020-12-03 ✅ Patent 12,297,266 granted on 2025-05-13Agonistic antibodies that bind human CD40 and uses thereof
#18 | 2020-11-26 ✅ Patent 10,941,201 granted on 2021-03-09Methods of inducing or enhancing an immune response comprising administering agonistic anti-CD40 antibodies
#19 | 2020-05-21 ✅ Patent 11,091,559 granted on 2021-08-17Anti-ALK antibodies and methods for use thereof
#20 | 2020-04-09 ✅ Patent 11,459,393 granted on 2022-10-04Anti-CD27 and anti-PD-L1 antibodies and bispecific constructs
#21 | 2020-01-23USE OF ANTI-PD-1 ANTIBODY IN COMBINATION WITH ANTI-CD27 ANTIBODY IN CANCER TREATMENT
#22 | 2019-11-07 ✅ Patent 11,541,076 granted on 2023-01-03Chimeric antigen receptors targeting TIM-1
#23 | 2019-10-24 ✅ Patent 10,633,444 granted on 2020-04-28Agonistic antibodies that bind CD40
#24 | 2019-05-23 ✅ Patent 10,774,146 granted on 2020-09-15Treatment of eosinophil or mast cell related disorders
#25 | 2019-05-23REGULATORS OF ANAPLASTIC LYMPHOMA KINASE AND USES THEREOF
#26 | 2019-04-11 ✅ Patent 10,781,267 granted on 2020-09-22Methods of treating by administering anti-kit antibodies
#27 | 2019-04-04 ✅ Patent 10,793,639 granted on 2020-10-06Methods of treating by administering anti-kit antibodies
#28 | 2018-12-20USES OF ANTI-HER3 ANTIBODIES FOR TREATING CANCER
#29 | 2018-06-21Biomarkers Related to Treatment of Cancer with HER3 and EGFR Inhibitors
#30 | 2018-03-08 ✅ Patent 10,865,244 granted on 2020-12-15Nucleic acids encoding agonistic antibodies that bind CD40
#31 | 2018-03-01Anti-MET Antibodies and Methods of Use Thereof
#32 | 2017-12-28 ✅ Patent 10,668,152 granted on 2020-06-02Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
#33 | 2017-08-24 ✅ Patent 10,745,490 granted on 2020-08-18Anti-ErbB antibodies and methods of use thereof
#34 | 2017-06-22 ✅ Patent 10,392,442 granted on 2019-08-27Use of anti-PD-1 antibody in combination with anti-CD27 antibody in cancer treatment
#35 | 2017-06-08 ✅ Patent 10,184,007 granted on 2019-01-22Methods of treating a kit-associated cancer by administering anti-kit antibodies
#36 | 2017-05-04 ✅ Patent 10,239,943 granted on 2019-03-26Treatment of eosinophil or mast cell related disorders
#37 | 2017-03-16 ✅ Patent 10,189,907 granted on 2019-01-29Polynucleotides encoding anti-KIT antibodies
#38 | 2016-10-27 ✅ Patent 9,605,081 granted on 2017-03-28Polynucleotides encoding anti-kit antibodies
#39 | 2015-11-26 ✅ Patent 11,180,566 granted on 2021-11-23Antibodies that bind human CD27 and uses thereof
#40 | 2012-10-04 ✅ Patent 9,580,503 granted on 2017-02-28Antibodies against T cell immunoglobulin domain and mucin domain 1 (TIM-1) antigen and uses thereof
#41 | 2012-08-23 ✅ Patent 9,051,615 granted on 2015-06-09Method of detecting and treating tuberous sclerosis complex associated disorders
Also check out Celldex Therapeutics, Inc.'s (Hampton, United States) applicant profile with 33 patent applications submitted.
122975 ⎘